John J Densmore

Title: John J Densmore - Innovator in Calcium Entry Pathway Research

Introduction

John J Densmore is an accomplished inventor based in Charlottesville, Virginia. He has made significant contributions to the field of cellular biology, specifically targeting the inhibition of calcium entry pathways in electrically non-excitable cells. With one patent to his name, Densmore's work focuses on anti-proliferative therapies that have potential applications in treating various diseases.

Latest Patents

Densmore's patent is titled "Inhibition of novel calcium entry pathway in electrically non-excitable cells acting as an anti-proliferative therapy." This innovative invention outlines methods for screening voltage-gated (VG)-selective inhibitors, alongside novel compositions designed to inhibit calcium entry into electrically non-excitable cells. The patent also encompasses methods of preventing proliferation of these cells and offers potential strategies for treating autoimmune diseases, preventing graft rejections, preventing apoptosis, and treating cancer.

Career Highlights

Currently, John J Densmore is part of the University of Virginia, where he continues to advance his research and contribute to the scientific community. His role at the university not only enhances his personal career but also impacts the development of therapeutic techniques in the medical field.

Collaborations

Densmore collaborates closely with notable colleagues, including Lloyd S Gray and Doris M Haverstick. Their combined expertise enables innovative research initiatives and contributes significantly to advancing the understanding of cellular mechanics and treatments.

Conclusion

John J Densmore's work exemplifies the spirit of innovation in the field of medical research. His contributions through his patented invention are paving the way for new therapies targeting autoimmune diseases and cancers, showcasing the vital role of inventors in advancing healthcare solutions.